- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Remus Pharmaceuticals Limited — Updates, 10-11-2025: Press Release
10-11-2025 | 03:01 pm
10-11-2025 | 03:01 pm
Remus Pharma's H1-FY26 consolidated PAT rose 33.97% to INR 17.50 Cr, with revenue up 46.80% to INR 400.20 Cr. Operational highlights include tender wins in Nicaragua, 37 new product approvals, a new therapeutic segment launch, and market entry into Algeria.
No comments yet. Be the first to comment!